Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-11-18
1997-08-12
Stone, Jacqueline M.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C07H 2100, A61K 4800
Patent
active
056567430
ABSTRACT:
Oligonucleotides capable of inhibiting the production of proliferation-associated proteins are provided. Oligonucleotides designed to be hybridizable with nucleic acids encoding nucleolar proteins are believed to be therapeutically useful. Certain of such oligonucleotides, hybridizable to portions of the gene coding for p120, especially the 3' untranslated region, were made and found to inhibit the synthesis of p120. The oligonucleotides of the invention are useful for the treatment of diseases characterized by hyperproliferation of cells such as malignancies, inflammatory and cardiovascular diseases. Treatment of human breast cell carcinoma, human epitheloid cervix carcinoma, human amelanotic melanoma, human renal cell carcinoma and other tumors are indicated.
REFERENCES:
patent: 5098890 (1992-03-01), Gewirtz et al.
Milligan et al, J. Medicinal Chemistry, 36(14):1923-1937 (1993).
Westermann et al, Biomed. Biochem. Acta, 48(1):85-93 (1989).
Bennett, Science, 271:434 (1996).
Bottenu et al. Nucleotide Sequence of the Gene for the b Subunit of Human Factor XIII Biochemistry 1900 29:11195-11209.
Mirabelli et al. In vitro and in vivo pharmacologic activities of antisense oligonucleotides Anti-Cancer Drug Design 1991 6:647-661.
Chiang et al. Antisense Oligonucleotides Inhibit Intercellular Adhesion Molecule 1 Expression by Two Distinct Mechanisms Journ. of Biol. Chem. 1991 206:18162-18171.
Perlaky et al. Growth Inhibition of Human Tumor Cell Lines by Antisense Oligonucleotides Designed to Inhibit p120 Expression Anti-Cancer Drug Design 1993 8:3-14.
Perlaky et al. Nucleolar and nuclear aberrations in human lox tumor cells following treatment with p120 antisense oligonucleotide Cancer Letters 1993 74:125-135.
Saijo et al. Cellular Pharmacology of p120 Antisense Oligodeoxynucleotide Phosphorothioate Oncology Research 1993 5:283-291.
Reed et al., Cancer Research, 50:6565-6570 (1990).
Anfossi et al., Proc. Natl. Acad. Sci USA, 86:3379-3383 (1989).
Fonagy et al., Proc. Am. Assoc. Cancer Res. Annu. Meet., 32:277 (1991).
Uhlmann et al., Chemical Reviews, 90(4):544-584 (1990).
Fonagy et al., Cancer Research, 54:1859-1864 (1994).
Fonagy et al., Cancer Research, 52:5250-5256 (1992).
Valdez et al., Cancer Research, 52:5681-5687 (1992).
Perlaky et al., Cancer Research, 52:428-436 (1992).
Tsujino et al., J. Biol. Chem., 264(26):15334-15337 (1989).
Busch H. et al., "Nucleolar Protein P120 and Its Targeting for Cancer Chemotherapy" Boll Soc. It Biol Sper. 67: 739-750 (1991).
Busch et al., "The Final Common Pathway of Cancer: Presidential Address" Cancer Res., 50: 4830-4838 (1990).
Calabretta, "Inhibition of Protooncogene Expression by Antisense Oligodeoxynucleotides: Biological and Therapeutic Implications" Cancer Res 51: 4505-4510 (1991).
Fonagy et al., "Cloning of the cDNA and Sequence of the Human Proliferating-Cell Nucleolar Protein P120" Cancer Commun. 1: 243-245 (1989).
Freeman and Bondada, "Inhibition of Cell Proliferation by Microinjection of Antibodies to Nucleolar Antigen p120" Proc. of the Am. Assoc. Cancer Res. 31: 261 (1990) (Abstract 1547).
Freeman et al., "Identification and Characterization of a Human Proliferation-Associated Nucleolar Antigen with a Molecular Weight of 120,000 Expressed in Early G.sub.1 " Cancer Res. 48: 1244-1251 (1988).
Freeman et al., "Prognostic Significance of Proliferation Associated Nucleolar Antigen P120 in Human Breast Carcinoma" Cancer Res. 51: 1973-1978 (1991).
Larson et al., "Genomic Structure of the Human Proliferating Cell Nucleolar Protein P120" Cancer Commun. 2: 63-71 (1990).
Ochs et al., "Intranucleolar Localization of Human Proliferating Cell Nucleolar Antigen p120" Cancer Res. 48: 6523-6529 (1988).
Rothenberg et al., "Oligodeoxynucleotides as Anti-Sense Inhibitors of Gene Expression: Therapeutic Implications" J. Natl. Cancer Inst. 81: 1539-1544 (1989).
Stein and Cohen, "Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review" Cancer Res. 48: 2659-2688 (1988).
Thompson and Gillespie, "Current Concepts in Quantitative Molecular Hybridization" Clin. Biochem 23: 261-266 (1990).
Zon, "Oligonucleotide Analogues as Potential Chemotherapeutic Agents", Pharmaceutical Research 5: 539-549 (1988).
Busch, et al., "Rabbit Antibodies to Nucleoli of Novikoff Hepatoma and Normal Liver of the Rat" Cancer Res. 34: 2362-2367 (1974).
Busch et al., "Liver Antigens Detected by Liver Antinucleolar Antibodies (40416)" Proc. Soc. Exp. Biol. Med. 160: 185-191 (1979).
Chiang et al., "Antisense Oligonucleotides Inhibit Intercellular Adhesion Molecule 1 Expression by Two Distinct Mechanisms" J. Biol. Chem. 18162-18171 (1991).
Davis et al., "Nucleolar Antigen Found in Several Human Tumors but not in the Nontumor Tissues Studied" Proc. Natl. Acad. Sci. U. S. A. 76: 892-896 (1979).
Hazlewood et al., "mRNA Levels for Human Nucleolar Protein P120 in Tumor and Nontumor Cells", Cancer Communications 01: 29-34 (1989).
Busch et al., "A Nucleolar Antigen Found in a Broad Range of Human Malignant Tumor Specimens" Cancer Res. 39: 3024-3030 (1979).
Saijo et al., "Pharmacology of P120 Antisense Oligonucleotide Phosphorothioates in Vitro" Experimental Biology 93 Abstract.
Smetana et al., "Nuclear Aberrations in Human Tumor Cells Following Treatment with P120 Antisense Oligonucleotide ISIS-3466" 1993 AACR ABstract Form.
Bennett Clarence Frank
Busch Harris
Busch Rose K.
Perlaky Laszlo
Saijo Yasuo
Baylor College of Medicine
Hogue, Jr. D. Curtis
ISIS Pharmaceuticals Inc.
Stone Jacqueline M.
LandOfFree
Oligonucleotide modulation of cell growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide modulation of cell growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide modulation of cell growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-161503